Coloplast A/S (OTCMKTS:CLPBF) is a Denmark‐based medical device company specializing in the development and manufacturing of products and services for people with intimate healthcare needs. Founded in 1957 by Aage Louis‐Hansen and Poul Mollgaard Jensen, the company set out to improve quality of life for patients requiring ostomy care, and has since expanded into multiple clinical areas. Coloplast is headquartered in Humlebæk, Denmark, and combines in‐house research and development with strategic partnerships to drive innovation in its core markets.
The company’s product portfolio is organized around four primary areas: ostomy care, continence care, wound and skin care, and interventional urology. In ostomy care, Coloplast offers pouches, barrier rings and accessory products designed for secure, long‐wearing solutions. Its continence care range includes catheters, drainage bags and skin protection items for individuals managing urinary or fecal incontinence. In wound and skin care, the firm provides advanced dressings, compression garments and negative pressure therapy systems, while its interventional urology division focuses on minimally invasive tools for the diagnosis and treatment of conditions affecting the urinary tract.
Coloplast operates through a network of subsidiaries in more than 40 countries and distributes products via third‐party partners in additional markets across Europe, North America, Asia‐Pacific, Latin America, the Middle East and Africa. The company’s global footprint is supported by local sales, marketing and clinical teams that work closely with healthcare professionals and patient organizations to tailor solutions to regional needs.
Throughout its history, Coloplast has maintained a commitment to user‐driven innovation, drawing on direct feedback from patients and clinicians. While the company’s leadership has evolved over time, its enduring focus remains on delivering products that address sensitive healthcare needs, improve patient comfort and uphold stringent quality standards.
